Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03964792 |
|---|---|
| Brief Title: | Safety and Efficacy of Gene Therapy of the Sickle Cell Disease by Transplantation of an Autologous CD34+ Enriched Cell Fraction That Contains CD34+ Cells Transduced ex Vivo With the GLOBE1 Lentiviral Vector Expressing the βAS3 Globin Gene in Patients With Sickle Cell Disease (DREPAGLOBE) (DREPAGLOBE) |
| First Submitted : | May 14, 2019 |
| First Submitted that Met QC Criteria : | May 24, 2019 |
| First Posted : | May 28, 2019 |
| Last Update Submitted that Met QC Criteria : | September 26, 2022 |
| Last Update Posted : | September 27, 2022 |